Answers are grounded in this paper and cite their sources.
Immobilization is a major cause of muscle atrophy in older adults, particularly in critically ill patients. Irisin is an exercise-induced myokine that supports muscle homeostasis, but its therapeutic potential for immobilization-induced muscle atrophy in older adults remains unclear. By measuring plasma irisin in respiratory care unit (RCU) patients and community-dwelling older adults, we found that RCU patients who were bedridden for ≥7 days had lower plasma irisin levels than community-dwelling older adults, and lower irisin levels were associated with a higher risk of thrombocytopenia. In aged immobilized mice, lipid nanoparticle (LNP)-encapsulated irisin circular RNA (circRNA) restored muscle weight and myofiber size and increased PAX7 immunostaining. Transcriptomic analysis identified suppression of FOXO1 and its downstream genes associated with cell-cycle arrest as a predicted mechanism promoting muscle regeneration. Collectively, these findings demonstrate LNP-encapsulated irisin circRNA as a potential therapeutic approach for immobilization-induced muscle atrophy in aging.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: